We regret to inform you that due to Blackrocks latest precautionary travel restrictions around the Covid-19 outbreak, Henry Shen will no longer be able to travel to Canada on March 25th. We hope we’ll be able to reschedule it soon. Thank you for your understanding.
Join us in a discussion on tackling the fastest growing segment of global equity markets and how it can help investors generate significant alpha in the space. MSCI recently added China A-shares in its emerging market and global indexes and BlackRock anticipated this backdrop and began investing onshore in China in 2012 as there is an early-movers' advantage.
Did you know?
Join us to discuss:
Henry Shen, Director - BlackRock
Henry Shen, Director, is a senior investment strategist within BlackRock's Systematic Active Equity (SAE) group. He is responsible for the growth of SAE's investment platform, with primary focuses on China-A, Asia Pacific, and Global Equity strategies.
Prior to his current role, Mr. Shen was a member of BlackRock's Asia ex-Japan Institutional Client Business group, responsible for developing and maintaining institutional relationships with clients and prospects in Taiwan and China.
Before joining BlackRock in 2012, Mr. Shen was a researcher at the Duke Medical Center and the University's Department of Biomedical Engineering. He is a published author for the Journal of Biomechanics.
Mr. Shen studied Biomedical Engineering and Economics, and received a Bachelor of Science in Engineering degree from Duke University.